Uses of Oxalgin DP 50mg/325mg Tablet
Oxalgin DP 50mg/325mg Tablet is used for the treatment or prevention of the following disease(s):
Pain Relief, Rheumatoid Arthritis
Side effects of Oxalgin DP 50mg/325mg Tablet
Precautions while taking Oxalgin DP 50mg/325mg Tablet
Dosage of Oxalgin DP 50mg/325mg Tablet
Overdose of Oxalgin DP 50mg/325mg Tablet
Onset of Action of Oxalgin DP 50mg/325mg Tablet
Duration of Action of Oxalgin DP 50mg/325mg Tablet
Precautions & Warnings
Alcohol
Information will be added soon.
Pregnancy
Information will be added soon.
Breastfeeding
Information will be added soon.
Driving
Information will be added soon.
Kidney
Information will be added soon.
Liver
Information will be added soon.
All substitutes for Oxalgin DP 50mg/325mg Tablet
For information purpose only. Refer to a healthcare professionals before consuming any medicines and/or drugs.
Interactions
Drug :-
acetaminophen: Increased risk of adverse renal effects with long-term concurrent use.
anticoagulants, thrombolytics: Prolonged PT, increased risk of bleeding.
antihypertensives: Decreased antihypertensive effectiveness.
aspirin, other NSAIDs, salicylates: Increased GI irritability and bleeding, decreased diclofenac effectiveness.
beta blockers: Impaired antihypertensive effect.
cefamandole, cefoperazone, cefotetan, plicamycin, valproic acid: Increased risk of hypoprothrombinemia.
cimetidine: Altered blood diclofenac level.
colchicine, corticotropin long-term use, glucocorticoids, potassium supplements:Increased GI irritability and bleeding.
cyclosporine, gold compounds, nephrotoxic drugs: Increased risk of nephrotoxicity.
digoxin: Increased blood digoxin level.
insulin, oral antidiabetics: Decreased effects of these drugs.
lithium: Increased risk of lithium toxicity.
loop diuretics: Decreased diuretic effects.
methotrexate: Increased risk of methotrexate toxicity.
phenytoin: Increased blood phenytoin level potassium-sparing diuretics: Increased risk of hyperkalemia.
probenecid: Increased diclofenac toxicity.
Food :-
food: Delayed absorption of delayed-release tablets.
Activity :-
alcohol use: Increased risk of GI irritability and bleeding.
Sonu Kumar is a registered pharmacist with Bihar State Pharmacy Council with over 6 months experience. He is a medicine content contributor at Health-Shoppe.com.
Dr. Naresh Dang is an MD in Internal Medicine. He has special interest in the field of Diabetes, and has over two decades of professional experience in his chosen field of specialty. Dr. Dang is an expert in the management of Diabetes, Hypertension and Lipids. He also provides consultation for Life Style Management.